πŸ‡ΊπŸ‡Έ FDA
Patent

US 10487054

Therapeutic compounds

granted A61PA61P17/14A61P35/00

Quick answer

US patent 10487054 (Therapeutic compounds) held by Regents of the University of Minnesota expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P17/14, A61P35/00